TITLE

Higher doses of radiation, methotrexate increased risk for second primary tumors of CNS

AUTHOR(S)
Harris, Jason; Lawrence, Leah; Volansky, Rob
PUB. DATE
December 2010
SOURCE
Hem/Onc Today;12/25/2010, Vol. 11 Issue 24, p39
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on a study which revealed increased risk for second primary tumors of central nervous system (CNS) following increased doses of methotrexate.
ACCESSION #
56533953

 

Related Articles

  • Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma. Gerber, David E.; Grossman, Stuart A.; Batchelor, Tracy; Xiaobu Ye // Cancer Chemotherapy & Pharmacology;Jun2007, Vol. 59 Issue 6, p817 

    High-dose methotrexate (HDMTX) (≥3 g/m2), the cornerstone of therapy for primary CNS lymphoma (PCNSL), is commonly dosed using a measured 24 h creatinine clearance (CrCl) every 2–4 weeks. Because these collections are cumbersome and at times unreliable, the use of a calculated CrCl...

  • Central Nervous System Prophylaxis With High-Dose Methotrexate Does Not Give Rise to Significant Electroencephalographic Changes in Children With Acute Lymphoblastic Leukemia. Korinthenberg, Rudolf; Schneider, Annette; Niemeyer, Charlotte // Journal of Child Neurology;Jun2002, Vol. 17 Issue 6, p409 

    Acute, subacute, and chronic neurologic complications have been reported in children treated with high-dose methotrexate for various malignant diseases. It was the aim of this study to monitor central nervous system treatment with high-dose methotrexate in children with acute lymphoblastic...

  • The Effects of Methotrexate on the Development of Neural Tube Defects in the Chick Embryo. Vatansever, H. Seda; Umur, A. Sükrü; Inan, V. Sevinç Selçuki, Mehmet // Turkish Journal of Veterinary & Animal Sciences;2003, Vol. 27 Issue 5, p1119 

    During chick development, one of the earliest differentiated tissues is the neural tube. After 24 h of incubation, a chick egg starts to differentiate and 30-48 h after incubation the neural plate is closed from head to tail to form the neural tube. If factors controlling the neural tube's...

  • Sarcoidosis. Wu, Jennifer J.; Schiff, Karin Rashcovsky // American Family Physician;7/15/2004, Vol. 70 Issue 2, p312 

    Sarcoidosis is a systemic granulomatous disease of unknown cause affecting young and middleaged adults. Patients commonly present with bilateral hilar lymphadenopathy, pulmonary infiltrates,and ocular and skin lesions. The heart, liver, spleen, salivary glands, muscles, bones, kidneys, and...

  • Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma. Fischer, Lars; Korfel, Agnieszka; Kiewe, Philipp; Neumann, Martin; Jahnke, Kristoph; Thiel, Eckhard // Annals of Hematology;Feb2009, Vol. 88 Issue 2, p133 

    Patients with malignant central nervous system (CNS) involvement of lymphoma have a poor prognosis with intrathecal chemotherapy and radiation. In this paper, we report the results we obtained in such patients by intravenous chemotherapy with high-dose methotrexate and ifosfamide (HDMTX/IFO)....

  • Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. Linnebank, M; Moskau, S; Kowoll, A; Semmler, A; Bangard, C; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Schmidt-Wolf, I G H; Pels, H; Schlegel, U // British Journal of Cancer;11/20/2012, Vol. 107 Issue 11, p1840 

    Background:Chemotherapy for primary central nervous system lymphoma (PCNSL) is based on methotrexate (MTX), which interferes with both nucleic acid synthesis and methionine metabolism. We have reported previously that genetic variants with influence on methionine metabolism are associated with...

  • Methotrexate.  // Reactions Weekly;3/14/2009, Issue 1243, p34 

    The article describes the case of a 6-year-old girl who acquired acute chorea. The patient, who is suffering from acute lymphoblastic leukemia, developed the said condition after undergoing prophylactic central nervous system (CNS) treatment with intrathecal methotrexate. She was administered...

  • Methotrexate.  // Reactions Weekly;4/20/2013, Issue 1449, p23 

    The article presents case studies of a 60-year-old woman and 75-year-old man with primary central nervous system lymphoma, who experienced grades 3 and 4 acute kidney injury while being treated with methotrexate.

  • Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study M Montemurro; T Kiefer; F Schüler; HK Al-Ali; H-H Wolf; R Herbst; A Haas; K Helke; A Theilig; C Lotze; C Hirt; D Niederwieser; M Schwenke; WH Krüger; G Dölken; For the Ostdeutsche Studiengruppe Hämatologie und Onkologie // Annals of Oncology;Apr2007, Vol. 18 Issue 4, p665 

    Background: We investigated the efficacy and safety of tandem high-dose methotrexate (HD-MTX) induction followed by high-dose busulfan/thiotepa (HD-BuTT) with autologous peripheral blood stem-cell transplantation (aPBSCT) and response-adapted whole-brain radiation therapy (WBRT) in patients with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics